InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Perspective Therapeutics, Inc.

CATX Clue Score36
United States Fiscal year ends December CIK 0000728387 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

128
Insider
Date
Role
Action
Shares
Price
Amount
Jonathan Robert Hunt
13 Nov 2025
Chief Accounting Officer
Buy
11,000
$2.03
$22.29K
Robert F Williamson III
12 Nov 2025
Director
Buy indirect
9,498
$2.10
$19.95K
Lori A Woods
31 Mar 2025
Director
Buy indirect
23,475
$2.13
$50.00K
Robert F Williamson III
31 Mar 2025
Director
Buy
38,145
$2.14
$81.78K
Juan Graham
28 Mar 2025
Chief Financial Officer
Buy
33,333
$2.25
$74.95K
Robert F Williamson III
28 Mar 2025
Director
Buy
22,192
$2.27
$50.38K
Johan M. Spoor
28 Mar 2025
Chief Executive Officer
Buy indirect
4,650
$2.21
$10.29K
Johan M. Spoor
28 Mar 2025
Chief Executive Officer
Buy
22,026
$2.24
$49.38K
Johan M. Spoor
4 Dec 2024
CEO
Buy
8,000
$3.77
$30.13K
Heidi Henson
4 Dec 2024
Director
Buy indirect
25,975
$3.85
$100.00K
Johan M. Spoor
25 Nov 2024
CEO
Buy indirect
6,600
$3.80
$25.08K
Johan M. Spoor
25 Nov 2024
CEO
Buy indirect
5,400
$3.80
$20.52K
Johan M. Spoor
25 Nov 2024
CEO
Buy
14,500
$3.78
$54.87K
Jonathan Robert Hunt
25 Nov 2024
Chief Financial Officer
Buy
10,000
$3.88
$38.80K
Jonathan Robert Hunt
25 Nov 2024
Chief Financial Officer
Buy
2,400
$3.60
$8.64K
Jonathan Robert Hunt
25 Nov 2024
Chief Financial Officer
Buy
29
$3.94
$114.26
Jonathan Robert Hunt
25 Nov 2024
Chief Financial Officer
Buy
400
$3.55
$1.42K
Robert F Williamson III
25 Nov 2024
Director
Buy
2,619
$3.67
$9.61K
Robert F Williamson III
25 Nov 2024
Director
Buy
3,647
$3.62
$13.20K
Jonathan Robert Hunt
17 Jun 2024
Chief Financial Officer
Buy
1,800
$9.82
$17.67K
Lori A Woods
14 Jun 2024
Director
Buy indirect
83
$10.80
$896.40
Lori A Woods
14 Jun 2024
Director
Buy indirect
4,504
$10.90
$49.09K
Johan M. Spoor
13 Jun 2024
CEO
Buy
100,000
$1.17
$117.43K
Lori A Woods
3 Jun 2024
Director
Buy indirect
34,246
$1.46
$49.99K
Robert F Williamson III
31 May 2024
Director
Buy
55,000
$1.38
$75.90K
Jonathan Robert Hunt
31 May 2024
Chief Financial Officer
Buy
12,000
$1.40
$16.80K
Jonathan Robert Hunt
31 May 2024
Chief Financial Officer
Buy
13,006
$1.40
$18.21K
Robert F Williamson III
29 May 2024
Director
Buy
18,656
$1.34
$25.00K
Robert F Williamson III
29 May 2024
Director
Buy
11,375
$1.32
$15.02K
Lantheus Alpha Therapy, LLC
6 Mar 2024
10% owner
Buy
60,431,039
$0.95
$57.41M
Robert F Williamson III
30 Jan 2024
Director
Buy
3,500
$0.70
$2.45K
Robert F Williamson III
30 Jan 2024
Director
Buy
42,879
$0.72
$30.87K
Robert F Williamson III
30 Jan 2024
Director
Buy
57,121
$0.71
$40.56K
Robert F Williamson III
30 Jan 2024
Director
Buy
5,127
$0.71
$3.64K
Robert F Williamson III
30 Jan 2024
Director
Buy
18,579
$0.71
$13.19K
Robert F Williamson III
29 Jan 2024
Director
Buy
21,235
$0.64
$13.59K
Robert F Williamson III
29 Jan 2024
Director
Buy
4,031
$0.64
$2.58K
Robert F Williamson III
26 Jan 2024
Director
Buy
50,000
$0.54
$27.00K
Robert F Williamson III
26 Jan 2024
Director
Buy
25,000
$0.55
$13.75K
Robert F Williamson III
26 Jan 2024
Director
Buy
8,513
$0.59
$5.02K
Robert F Williamson III
26 Jan 2024
Director
Buy
14,850
$0.61
$9.06K
Robert F Williamson III
26 Jan 2024
Director
Buy
12,250
$0.61
$7.47K
Robert F Williamson III
25 Jan 2024
Director
Buy
22,134
$0.49
$10.85K
Robert F Williamson III
24 Jan 2024
Director
Buy
29,862
$0.49
$14.63K
Markus Puhlmann
24 Jan 2024
Chief Medical Officer
Buy
280,000
$0.50
$139.89K
Robert F Williamson III
21 Dec 2023
Director
Buy indirect
3,663
$0.33
$1.20K
Markus Puhlmann
19 Dec 2023
Chief Medical Officer
Buy
400,000
$0.34
$137.00K
Robert F Williamson III
19 Dec 2023
Director
Buy
13,680
$0.32
$4.38K
Markus Puhlmann
18 Dec 2023
Chief Medical Officer
Buy
60,419
$0.26
$15.46K
Robert F Williamson III
18 Dec 2023
Director
Buy
10,000
$0.26
$2.60K
Jonathan Robert Hunt
18 Dec 2023
Chief Financial Officer
Buy
125,000
$0.26
$32.34K
Lori A Woods
15 Dec 2023
Director
Buy indirect
152,962
$0.27
$41.28K
Markus Puhlmann
15 Dec 2023
Chief Medical Officer
Buy
135,006
$0.27
$36.28K
Lori A Woods
14 Dec 2023
Director
Buy indirect
32,238
$0.27
$8.70K
Jonathan Robert Hunt
5 Dec 2022
Chief Financial Officer
Buy
32,200
$0.38
$12.24K
Jonathan Robert Hunt
1 Dec 2022
Chief Financial Officer
Buy
53,204
$0.38
$20.27K
Lori A Woods
15 Nov 2022
CEO
Buy indirect
100,000
$0.34
$33.54K
Mark John Austin
9 Jun 2022
VP Finance/Prin Fin&Acct Offic
Buy
13,800
$0.29
$3.96K
Jonathan Robert Hunt
8 Jun 2022
Chief Financial Officer
Buy
25,675
$0.29
$7.44K
Mark John Austin
8 Jun 2022
VP Finance/Prin Fin&Acct Offic
Buy
5,000
$0.29
$1.43K
Jonathan Robert Hunt
7 Jun 2022
Chief Financial Officer
Buy
13,325
$0.28
$3.72K
Lori A Woods
7 Jun 2022
CEO
Buy indirect
75,000
$0.30
$22.23K
Lori A Woods
30 Nov 2020
CEO
Buy indirect
68,000
$0.38
$25.53K
Lori A Woods
22 Oct 2020
CEO
Buy
48,076
$0.52
$25.00K
Philip J Vitale
22 Oct 2020
Director
Buy indirect
20,000
$0.52
$10.40K
Alan Hoffmann
22 Oct 2020
Director
Buy
19,230
$0.52
$10.00K
Michael W McCormick
22 Oct 2020
Director
Buy
19,230
$0.52
$10.00K
William Cavanagh
22 Oct 2020
Chief R&D Officer
Buy
7,692
$0.52
$4.00K
Jonathan Robert Hunt
22 Oct 2020
Chief Financial Officer
Buy
67,306
$0.52
$35.00K
Michael Krachon
22 Oct 2020
EVP of Sales & Marketing
Buy
28,844
$0.52
$15.00K
Mark John Austin
22 Oct 2020
Controller/Prin Fin&Acct Offic
Buy
19,230
$0.52
$10.00K
Michael Krachon
20 Nov 2019
VP of Sales & Marketing
Buy indirect
50,000
$0.39
$19.50K
William Cavanagh
15 Nov 2019
Chief R&D Officer
Buy
10,000
$0.39
$3.90K
Lori A Woods
15 Nov 2019
CEO
Buy
25,000
$0.39
$9.75K
Lori A Woods
14 Nov 2019
CEO
Buy
125,000
$0.40
$49.55K
Alan Hoffmann
20 Nov 2018
Director
Buy indirect
25,000
$0.40
$10.00K
William Cavanagh
16 Nov 2018
COO, CSO
Buy
10,000
$0.40
$4.00K
Mark John Austin
16 Nov 2018
Controller/Prin Fin&Acct Offic
Buy
4,283
$0.40
$1.70K
Lori A Woods
15 Nov 2018
Interim CEO
Buy
635
$0.40
$251.84
Lori A Woods
15 Nov 2018
Interim CEO
Buy
4,365
$0.40
$1.74K
Lori A Woods
14 Nov 2018
Interim CEO
Buy
125,000
$0.40
$49.74K
Philip J Vitale
13 Nov 2018
Director
Buy
30,000
$0.43
$12.90K
Mark John Austin
13 Nov 2018
Controller/Prin Fin&Acct Offic
Buy
2,452
$0.41
$1.01K
Philip J Vitale
14 Mar 2018
Director
Buy
10,000
$0.44
$4.40K
Thomas C Lavoy
1 Mar 2018
CEO and Chairman of the Board
Buy
45,814
$0.44
$20.16K
Thomas C Lavoy
1 Mar 2018
CEO and Chairman of the Board
Buy
4,186
$0.43
$1.80K
Mark John Austin
24 Nov 2017
Controller/Prin Fin&Acct Offic
Buy
1,025
$0.49
$502.25
Mark John Austin
24 Nov 2017
Controller/Prin Fin&Acct Offic
Buy
515
$0.50
$254.93
Mark John Austin
24 Nov 2017
Controller/Prin Fin&Acct Offic
Buy
500
$0.50
$247.50
Mark John Austin
22 Nov 2017
Controller/Prin Fin&Acct Offic
Buy
1,825
$0.49
$894.25
Mark John Austin
21 Nov 2017
Controller/Prin Fin&Acct Offic
Buy
3,400
$0.49
$1.65K
Mark John Austin
21 Nov 2017
Controller/Prin Fin&Acct Offic
Buy
2,000
$0.47
$942.00
Michael Krachon
20 Nov 2017
VP of Sales & Marketing
Buy
3,900
$0.48
$1.87K
Michael Krachon
20 Nov 2017
VP of Sales & Marketing
Buy
100
$0.48
$48.00
Michael Krachon
20 Nov 2017
VP of Sales & Marketing
Buy
200
$0.47
$94.00
Michael Krachon
20 Nov 2017
VP of Sales & Marketing
Buy
200
$0.48
$96.00
Michael Krachon
20 Nov 2017
VP of Sales & Marketing
Buy
40
$0.49
$19.60
Michael Krachon
20 Nov 2017
VP of Sales & Marketing
Buy
300
$0.47
$141.00
Michael Krachon
20 Nov 2017
VP of Sales & Marketing
Buy
10,160
$0.50
$5.08K
Michael Krachon
20 Nov 2017
VP of Sales & Marketing
Buy
200
$0.46
$92.00
Michael Krachon
20 Nov 2017
VP of Sales & Marketing
Buy
500
$0.47
$235.00
Michael Krachon
20 Nov 2017
VP of Sales & Marketing
Buy
126
$0.47
$59.22
Michael Krachon
20 Nov 2017
VP of Sales & Marketing
Buy
1,400
$0.50
$700.00
Michael Krachon
20 Nov 2017
VP of Sales & Marketing
Buy
700
$0.50
$350.00
Michael Krachon
20 Nov 2017
VP of Sales & Marketing
Buy
10,600
$0.50
$5.30K
Michael Krachon
20 Nov 2017
VP of Sales & Marketing
Buy
6,965
$0.50
$3.48K
Michael Krachon
20 Nov 2017
VP of Sales & Marketing
Buy
19,609
$0.50
$9.80K
Philip J Vitale
16 Nov 2017
Director
Buy
100
$0.44
$44.40
Philip J Vitale
16 Nov 2017
Director
Buy
600
$0.45
$269.40
Philip J Vitale
16 Nov 2017
Director
Buy
12,851
$0.45
$5.78K
Philip J Vitale
16 Nov 2017
Director
Buy
300
$0.44
$132.75
Philip J Vitale
16 Nov 2017
Director
Buy
300
$0.44
$130.86
Philip J Vitale
16 Nov 2017
Director
Buy
496
$0.44
$218.19
Philip J Vitale
16 Nov 2017
Director
Buy
1,606
$0.44
$706.64
Philip J Vitale
16 Nov 2017
Director
Buy
1,400
$0.44
$614.60
Philip J Vitale
16 Nov 2017
Director
Buy
18
$0.44
$7.83
Philip J Vitale
16 Nov 2017
Director
Buy
3,049
$0.44
$1.34K
Philip J Vitale
16 Nov 2017
Director
Buy
400
$0.44
$175.56
Philip J Vitale
16 Nov 2017
Director
Buy
200
$0.43
$86.08
Philip J Vitale
16 Nov 2017
Director
Buy
8,480
$0.43
$3.65K
Philip J Vitale
16 Nov 2017
Director
Buy
100
$0.43
$42.51
Philip J Vitale
16 Nov 2017
Director
Buy
100
$0.43
$42.50
Thomas C Lavoy
10 Mar 2017
CEO
Buy
20,000
$0.53
$10.60K
Philip J Vitale
4 Jan 2017
Director
Buy
2,700
$0.66
$1.77K
Philip J Vitale
4 Jan 2017
Director
Buy
100
$0.66
$65.75
Philip J Vitale
4 Jan 2017
Director
Buy
17,200
$0.66
$11.35K
Alan Hoffmann
8 Dec 2016
Director
Buy indirect
20,000
$0.57
$11.40K
Thomas C Lavoy
17 Nov 2016
CEO
Buy
20,000
$0.60
$12.00K
Show all 152 transactions →

What was left out

Form 4 filings counted 168
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 1,018,748
History held since 26 Oct 2006